The Washington Times
  • Subscribe
  • Times News Services
  • RSS
  • Mobile Headlines
  • e-edition
  • E-MAIL ALERTS
  • REGISTER
  • LOG IN
  • E-MAIL ALERTS
  • WELCOME
  • Your Profile
  • Log Out
  • Front Page Image
  • Classifieds
  • Autos
  • Real Estate
  • Jobs
  • Special Sections
  • Customer Service
  • Home
  • News
  • Opinion
  • Sports
    • NFL
    • NBA/WNBA
    • MLB
    • NHL
    • Tennis
    • Golf
    • Motorsports
    • Soccer
    • NCAA
    • Olympics
    • Outdoors
    • Other
  • Culture
    • Home & Living
    • Family & Kids
    • Fashion
    • Food
    • Travel
    • Health
    • Washington Visitors
    • Books
    • Military History
    • Life
    • Auto
    • TV Listings
    • Movie Listings
    • Death Notices
    • Entertainment
  • Themes
  • Communities
  • Shopping
    • Stores
    • Coupons
    • Daily Double
    • Promotion
    • How It Works
  • Videos
    • Two Guys
    • Birnbaum on Washington
    • Liz Glover
    • Amanda Carpenter
    • Morning Briefing
    • Documentaries
    • Joe Giganti
    • Video Game Minute
  • Podcasts
    • About Headlines
    • Audio and Radio
    • America's Morning News
  • Commentary

    Suicide pact

  • World

    Italian arrests tied to '08 Mumbai attacks

  • Culture

    DESIGN: Exhibits trace decades-old fashion, fabric trends

  • Investigation

    Anglers serve time for black-market rockfish trade

  • World

    Islamic center in Maryland keeps ties to Iran

  • Politics

    ANALYSIS: Obama takes a bow, but applause is weak

  • Politics

    Republican governors: 'Opt out' unworkable

Home » News » Editor Favorites

Tuesday, June 17, 2008

VA testing drugs on war veterans

Rate this story

Average 0.00
after 0 votes
Login or register to rate this story

Experiments raise ethical questions

  • Font Size -+
  • Print
  • Email
  • Comment
  • Tweet this!
  • Share
  • Article
  • Comments ()
  • Click-2-Listen
  • Videos
Please stand by, images loading!
  • ROD LAMKEY JR./THE WASHINGTON TIMES
Veteran James Elliott arrives at the Veterans Affairs Medical Center in Washington for his scheduled substance-abuse class in April. Mr. Elliott, a chain smoker, served 15 months in Iraq as an Army sharpshooter and suffers post-traumatic stress disorder.
  • Iraq war veteran James Elliott opted for a government clinical trial for a smoking-cessation drug for $30 a month, starting in November. Two weeks later, the FDA informed the VA of serious side effects. (Rod Lamkey Jr./The Washington Times)
  • ROD LAMKEY JR./THE WASHINGTON TIMES
STILL SMOKING: Iraq war veteran James Elliott smokes on his porch in Silver Spring as he talks about his experiences in war and dealing with post-traumatic stress disorder. Mr. Elliott suffered a psychotic episode while taking the anti-smoking drug Chantix.

More Editor Favorites Stories

  • Suicide pact
  • Italian arrests tied to '08 Mumbai attacks
  • DESIGN: Exhibits trace decades-old fashion, fabric trends
  • Anglers serve time for black-market rockfish trade

By Audrey Hudson

UPDATE: Obama's office sent a letter Tuesday to James Peake, secretary of the Department of Veterans Affairs, on the issue. You can read the full text of the letter here.

UPDATE II: Sen. John Cornyn, Texas Republican, issued his own letter to Peake as well. You can read it here.

The government is testing drugs with severe side effects like psychosis and suicidal behavior on hundreds of military veterans, using small cash payments to attract patients into medical experiments that often target distressed soldiers returning from Iraq and Afghanistan, a Washington Times/ABC News investigation has found.

In one such experiment involving the controversial anti-smoking drug Chantix, the Department of Veterans Affairs (VA) took three months to alert its patients about severe mental side effects. The warning did not arrive until after one of the veterans taking the drug had suffered a psychotic episode that ended in a near lethal confrontation with police.

James Elliott, a decorated Army sharpshooter who suffers from post-traumatic stress disorder (PTSD) after serving 15 months in Iraq, was confused and psychotic when he was Tasered by police in February as he reached for a concealed handgun when officers responded to a 911 call at his Maryland home.

For photos, video of James Elliott, official FDA documents and more, visit the interactive site for theDisposable Heroes report.

Mr. Elliott, a chain smoker, began taking Chantix last fall as part of a VA experiment that specifically targeted veterans with PTSD, opting to collect $30 a month for enrolling in the clinical trial because he needed cash as he returned to school. He soon began suffering hallucinations and suicidal thoughts, unaware that the new drug he was taking could have caused them.

Just two weeks after Mr. Elliott began taking Chantix in November, the VA learned from the Food and Drug Administration (FDA) that the drug was linked to a large number of hallucinations, suicide attempts and psychotic behavior. But the VA did not alert Mr. Elliott before his own episode in February.

In failing to do so, Mr. Elliott said, the VA treated him like a "disposable hero."

"You're a lab rat for $30 a month," Mr. Elliott said.

[Get Copyright Permissions] Click here for reprint permissions!
Copyright 2009 The Washington Times, LLC

12345678Next »

Post a comment

There are comments on this article, submit your opinion!

Please login or register to post a comment

Ask a Question

You Report

Do you have another point of view, photos, audio, video or more information about a story?

Top Stories

Most Read

  1. Massive bill steals show in health care debate
  2. Report: D.C. schools chief Rhee mishandled sexual misconduct scandal
  3. Islamic center in Maryland keeps ties to Iran
  4. Religious leaders vow civil disobedience on anti-life issues
  5. EDITORIAL EXCLUSIVE: On terrorists, Justice recused
More Top Stories »
  1. KELLNER: New Apple mouse really is 'Magic'
  2. EXCLUSIVE: Hoffman considering recount claim
  3. Senate health care bill creates new marriage penalty
  4. EDITORIAL: Gunning for Sarah Palin
  5. Report: ACORN mismanaged grant money

Most Shared

  1. EDITORIAL EXCLUSIVE: On terrorists, Justice recused
  2. Islamic center in Maryland keeps ties to Iran
  3. Religious leaders vow civil disobedience on anti-life issues
  4. EDITORIAL: Gunning for Sarah Palin
  5. Senate health care bill creates new marriage penalty
More Top Stories »
  1. Couples delay divorce, wait out recession
  2. Anglers serve time for black-market rockfish trade
  3. 20-pound, 2,074-page bill steals show
  4. Work site arrests of illegals fall dramatically
  5. Military academies lack minority nominees

Most Commented

  1. Work site arrests of illegals fall dramatically
  2. Religious leaders vow civil disobedience on anti-life issues
  3. ANALYSIS: Obama takes a bow, but applause is weak
  4. Senate Democrats win key vote on health bill
  5. Islamic center in Maryland keeps ties to Iran
More Top Stories »
  1. Obama's approval rating falls below 50%
  2. Massive bill steals show in health care debate
  3. EDITORIAL: Gunning for Sarah Palin
  4. Military academies lack minority nominees
  5. 20-pound, 2,074-page bill steals show

Listen to Washington Times Radio

  • America's Morning News

    with John McCaslin and Melanie Morgan

Question of the day

White House officials and Senate Democrats met in private three times last week to craft health care legislation. Do you think these discussions should be more public?

Blogs & Columns

  • Hot Button Blog

    RNC: Breast cancer recommendations may lead to 'rationing'

  • Belief Blog

    Evangelicals OK civil disobedience

  • Out of Context

    Foods that might kill libido

  • On the Fly

    United lifts some 'award' blocking

  • Technology

    Facebook wins round against phishing spammer

  • Redskins 360

    Rinehart looks badly hurt

  • SNOBlog

    Beyond 'Woody'

Videos

Advertising Links
TWT Store
  • e-edition
  • Print Edition
  • Weekly Washington Times
TWT Affiliates
  • Middle East Times
  • Golf
  • UPI
  • Arbor Ballroom
  • Washington Times Global
  • About TWT
  • Press Room
  • F.A.Q.
  • Work for TWT
  • Advertise
  • Sponsors
  • Contact Us
  • Privacy Policy
  • Site Map

All site contents © Copyright 2009 The Washington Times, LLC.